Companies

F.T.C. Settles With Express Scripts Over High Insulin Prices

February 4, 2026

Cigna's Express Scripts has settled with the Federal Trade Commission (FTC) over allegations of inflating insulin prices through illegal rebate practices. As part of the settlement, the company will modify its pricing calculations for approved drugs, while the lawsuits against other major pharmacy benefit managers continue.

F.T.C. Settles With Express Scripts Over High Insulin Prices

Key Highlights

Cigna's Express Scripts agreed to changes to address allegations of inflated insulin prices.
The settlement follows a lawsuit filed by the FTC in 2024.
Express Scripts is one of three major pharmacy benefit managers controlling 80% of US prescriptions.
The FTC is still pursuing lawsuits against CVS Health Corp. and UnitedHealth Group Inc.
A hearing related to these ongoing cases has been postponed for settlement discussions.

United States Politics and Government Prices (Fares, Fees and Rates)Drugs (Pharmaceuticals)Insulin Diabetes Regulation and Deregulation of Industry Consumer Protection Express Scripts Inc Federal Trade Commission Biden, Joseph R Jr Trump, Donald J

Sources

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

F.T.C. Settles With Express Scripts Over High Insulin Prices

Key Highlights

Sources

Related Stories

₹2.65 lakh per square yard bid received for plot in Kukatpally; 1,400 sft flat sold for ₹1.10 crore

Want to be richer? ‘Rich Dad, Poor Dad’ author Robert Kiyosaki says, ‘AI will replace you’ IF…

CBSE Board Exams Live: Class 12 Chemistry Exam From 10:30 AM, Check Tips, Instructions